About Index Trending news
Lists
Pricing
Pulmatrix

Pulmatrix

Pulmatrix

Pulmatrix develops inhaled therapies for the treatment, prevention and transmission of infectious and progressive respiratory diseases.

Elsewhere

Contributors to this profile

Alexa global traffic share

16 Jun 2015
$10,000,000
Angel
Added by

Pulmatrix Raises $10 Million Private Placement; To Begin Trading on NASDAQ under "PULM"

prnewswire
02 Nov 2009
$30,200,000
Venture capital (Series B)
11 Mar 2009
$3,500,000
Venture capital (Series A)